Get In Touch

Anti-anginal drugs are also known as anti-anginal agents. The management of angina is done through a variety of anti-anginal drugs. Angina is a heart condition in which the arteries of the heart, known as coronary arteries, become narrow. The primary symptom associated with angina is severe chest pain. Anti-anginal agents include nitrates, calcium antagonists, beta blockers, and Ranolazine. Examples of nitrates include nitroglycerin, isosorbide mono-nitrate, and isosorbide di-nitrate. These drugs help by relaxing the smooth muscle inside the blood vessels, making it wide and helping in the easy transfer of oxygen and blood to the heart. Examples of the calcium antagonists include verapamil, nimodipine, nifedipine, and diltiazem. These antagonists inhibit the contraction of the vascular smooth muscles due to their ability to inhibit calcium transfer into the cells. Examples of beta blockers include metoprolol, pindolol, propranolol, and atenolol. These drugs help in slowing down the heartbeat.

The exact way in which Ranolazine exerts its anti-anginal effect is not yet known. It is assumed that during cardiac repolarization, Ranolazine inhibits the ion channels. Anti-anginal drugs help in the treatment of Raynaud's syndrome, pulmonary hypertension, high blood pressure, heart failure, heart attack, esophageal spasm, cyanide poisoning, angina pectoris prophylaxis, angina, and anal fissure and fistula. Raynaud's syndrome is an indication of blockage of blood flow to the nose, ears, toes, and fingers, causing blood vessel spasms due to experiencing of strong emotions or cold temperatures. Pulmonary hypertension occurs due to narrowing of the small arteries of the lung, making it difficult for the blood to flow, thereby increasing the blood pressure. Under this condition, the right side of the heart pumps blood harder. Hence, the size of the heart increases over a period of time, resulting in heart failure. Heart failure is a condition in which the heart is not able to transfer nutrients and oxygen to the rest of the body. Heart attack is a condition of permanent damage or death of an area of the heart muscle due to inadequate supply of oxygen to that part of the heart. Esophageal spasms occur when the food in the esophagus does not effectively propel down to the stomach due to irregular contractions of muscles in the esophagus. The measures undertaken to prevent discomfort due to coronary heart disease or chest pain is known as angina pectoris prophylaxis. Rise in prevalence of Raynaud's syndrome, pulmonary hypertension, high blood pressure, heart failure, heart attack, esophageal spasms, cyanide poisoning, angina pectoris prophylaxis, angina, and anal fissure and fistula is projected to drive the anti-anginal drugs market during the forecast period. According to the Raynaud’s Association, 15 million to 30 million people in the U.S. are affected with Raynaud's syndrome.

The global anti-anginal drugs market can be segmented on the basis of mode of action, indication, dosage form, distribution channel, and region. Based on mode of action, the anti-anginal drugs market can be categorized into nitrates, calcium antagonists, beta blockers, and Ranolazine. In terms of indication, the anti-anginal drugs market can be classified into Raynaud's syndrome, pulmonary hypertension, high blood pressure, heart failure, heart attack, esophageal spasms, cyanide poisoning, angina pectoris prophylaxis, angina, and anal fissure and fistula. Based on dosage form, the anti-anginal drugs market can be divided into ointments and tablets. In terms of distribution channel, the anti-anginal drugs market can be bifurcated into retail pharmacies, online pharmacies, and hospital pharmacies.

Geographically, the global anti-anginal drugs market can be segmented into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America accounted for the dominant share of the anti-anginal drugs market in 2016 due to increase in prevalence of the heart failure and heart attack in the region. Europe constituted the next leading share of the anti-anginal drugs market share in 2016 owing to increase in prevalence of high blood pressure in the region. The anti-anginal drugs market in Asia Pacific is anticipated to expand at a significant rate during the forecast period. The anti-anginal drugs market in Middle East & Africa and Latin America is projected to expand during the forecast period owing to increase in initiatives undertaken by the governments to prevent incidences of heart attack and heart failure in these regions.

Key players operating in the global anti-anginal drugs market include Pfizer Inc., MEDA Manufacturing GmbH, Valeant Pharmaceuticals International, Inc., and Gilead Sciences.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Anti Anginal Drugs Market

Pre Book